Effects of antidepressant treatment on neuroactive steroids in major depression.
about
Neurosteroids and GABA(A) Receptor Interactions: A Focus on StressPregnenolone rescues schizophrenia-like behavior in dopamine transporter knockout mice.Finasteride induced depression: a prospective studyMedroxyprogesterone acetate antagonizes the effects of estrogen treatment on social and sexual behavior in female macaques.In a mouse model relevant for post-traumatic stress disorder, selective brain steroidogenic stimulants (SBSS) improve behavioral deficits by normalizing allopregnanolone biosynthesis.Neurosteroids' effects and mechanisms for social, cognitive, emotional, and physical functionsNeurosteroids in the context of stress: implications for depressive disordersRole of microsomal retinol/sterol dehydrogenase-like short-chain dehydrogenases/reductases in the oxidation and epimerization of 3alpha-hydroxysteroids in human tissuesNeurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsRecent developments in the significance and therapeutic relevance of neuroactive steroids--Introduction to the special issueThe role of reproductive hormones in postpartum depressionAllopregnanolone as a mediator of affective switching in reproductive mood disordersStress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsyTranslocator protein-mediated pharmacology of cholesterol transport and steroidogenesisThe neurosteroid allopregnanolone increases dopamine release and dopaminergic response to morphine in the rat nucleus accumbensGABAA receptor-acting neurosteroids: a role in the development and regulation of the stress responseBeyond the HPA Axis: Progesterone-Derived Neuroactive Steroids in Human Stress and EmotionThe rate of change in declining steroid hormones: a new parameter of healthy aging in men?The GABAergic deficit hypothesis of major depressive disorder.Neurosteroids reduce social isolation-induced behavioral deficits: a proposed link with neurosteroid-mediated upregulation of BDNF expression.Manipulation of GABAergic steroids: Sex differences in the effects on alcohol drinking- and withdrawal-related behaviors.Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressantsNeuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women.Simultaneous quantification of GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in human and rat serum.Premenstrual syndrome, neuroactive steroids and the brain.Neurosteroids and GABAergic signaling in health and diseaseDifferential effects of ethanol on serum GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in mice, rats, cynomolgus monkeys, and humans.GABA(A)R plasticity during pregnancy: relevance to postpartum depression.Progesterone withdrawal increases the alpha4 subunit of the GABA(A) receptor in male rats in association with anxiety and altered pharmacology - a comparison with female rats.Neuropathic pain promotes adaptive changes in gene expression in brain networks involved in stress and depressionAllopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects.Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?Antidepressant-like effects of methanol extract of Hibiscus tiliaceus flowers in mice.Allopregnanolone elevations following pregnenolone administration are associated with enhanced activation of emotion regulation neurocircuits.Influence of mirtazapine on plasma concentrations of neuroactive steroids in major depression and on 3alpha-hydroxysteroid dehydrogenase activity.The influence of hormones and pharmaceutical agents on DHEA and DHEA-S concentrations: a review of clinical studies.A new look at the 5alpha-reductase inhibitor finasteride.Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor SyndromeNeurosteroid biosynthesis downregulation and changes in GABAA receptor subunit composition: A biomarker axis in stress-induced cognitive and emotional impairment.Neuroactive steroids in depression and anxiety disorders: clinical studies.
P2860
Q21129366-AB9A6092-B885-4761-B8C5-420B6D939774Q21133801-657A43D5-6717-4F89-9DD1-A7A5B00D13FAQ21254638-769A7657-6E0D-4A97-ACCF-5108DCA93148Q24542881-4F89919F-22AC-4B5E-9E2F-D8B6B5692764Q24605563-64B04343-82A8-4C53-A0F0-F78DDF951956Q24618586-2DD0E606-B7E4-4053-A218-138DF13ECAA7Q24646222-B3A0380E-36A3-43C2-A145-F6D5D5F60F2FQ24649074-5A95A6CA-C149-4ECF-B513-2A5B272DB264Q24656267-E2D92F19-0CB9-42EE-988D-47DC5C321E07Q24670760-3C44FF92-C8B6-466F-B910-0D603C1F9436Q26849873-5D49387A-FC96-426F-A009-03B3987A6DBEQ26866177-10433EEC-FCF2-45B6-91A0-60607C3C30C4Q27013911-0B3E93E8-D4B2-40D2-8097-8A32DCD5804BQ28083751-81174006-51DC-432B-8EFC-D97431FAAAF7Q28216689-B5D7E5F3-D965-4190-8B64-2D0A647C13D5Q28241963-67BA961D-64F6-4978-9149-E6862254F12DQ28729887-758AB6C9-5D19-4118-93CB-C1A1AE1DDAD7Q29048619-E7DE1E3A-BB72-4A42-95E5-73AA55F40EBEQ30464954-911F6B2D-F337-4C5D-B549-6783844EA193Q30467322-024B55CE-949C-45B7-A12C-407A3AD67475Q30477804-06EEC688-7104-42FE-ACE3-A66889BD6A70Q30887852-71C11FDF-AB32-442A-8AA3-78F7774C16F1Q33628099-BFDF8D7C-AF02-4967-A3E0-3E649ECD43BAQ33703907-9C3F5188-3C9E-447A-A34F-3D70BBEDE49EQ33714290-4D89EA05-3497-4DE1-A787-EC91DD84ECB9Q33792908-6339C915-8958-4730-A59E-8DBC924570DCQ33805010-0B78E135-0E2C-429B-8E0E-2712D0AD57E5Q33872187-6ABAF82C-A201-4097-A84A-1BCCE63B3E3CQ33919784-4BF6499A-0296-4AE1-86D8-19CF9F74991BQ33925526-B1CDC32E-5E4C-4723-AEE9-8C21A2D66303Q34007510-F340E782-49D8-4301-A882-E50800D8E30DQ34054017-F34BFEC3-72C1-4AF0-9F4E-89360E3FA854Q34228981-F92FD5C6-6C22-4E91-8943-04EEF4CC418FQ34324221-7EFB926B-4F52-4547-BD9B-1FEE173C89CFQ34475376-31A7160B-3696-48A1-99C4-BEF1C465CF18Q34544099-5540FAB5-0F8B-4435-B897-3D9457B6A022Q34546591-821D77F6-710C-4B05-9E33-E202461042C5Q34552026-31874868-4AF4-4CCE-A8E0-71960A19E3DDQ34556039-C90EC3AC-35D8-48C1-9582-84439E5E2958Q34589630-58BDDEC8-92BE-4454-93AC-61DB4576B402
P2860
Effects of antidepressant treatment on neuroactive steroids in major depression.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Effects of antidepressant treatment on neuroactive steroids in major depression.
@ast
Effects of antidepressant treatment on neuroactive steroids in major depression.
@en
Effects of antidepressant treatment on neuroactive steroids in major depression.
@nl
type
label
Effects of antidepressant treatment on neuroactive steroids in major depression.
@ast
Effects of antidepressant treatment on neuroactive steroids in major depression.
@en
Effects of antidepressant treatment on neuroactive steroids in major depression.
@nl
prefLabel
Effects of antidepressant treatment on neuroactive steroids in major depression.
@ast
Effects of antidepressant treatment on neuroactive steroids in major depression.
@en
Effects of antidepressant treatment on neuroactive steroids in major depression.
@nl
P2093
P356
P1476
Effects of antidepressant treatment on neuroactive steroids in major depression.
@en
P2093
Rupprecht R
Spalletta G
di Michele F
P304
P356
10.1176/AJP.155.7.910
P407
P577
1998-07-01T00:00:00Z